Physicochemical properties and Mycobacterium tuberculosis transporters: keys to efficacious antitubercular drugs?

作者: Elizabeth Fullam , Robert J. Young

DOI: 10.1039/D0MD00265H

关键词:

摘要: Securing novel, safe, and effective medicines to treat Mycobacterium tuberculosis remains an elusive goal, particularly influenced by the largely impervious Mtb envelope that limits exposure thus efficacy of inhibitors at their cellular periplasmic targets. The impact physicochemical properties on pharmacokinetic parameters govern oral absorption sites infection is considered alongside how these influence penetration envelope, with likely transporter proteins. findings are discussed benchmark current drugs emerging pipeline, whilst considering tactics for future rational targeted design strategies, based around data transporters structures functions.

参考文章(95)
M. Gopal, N. Padayatchi, J. Z. Metcalfe, M. R. O'Donnell, Systematic review of clofazimine for the treatment of drug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. ,vol. 17, pp. 1001- 1007 ,(2013) , 10.5588/IJTLD.12.0144
G A Snow, Mycobactins: iron-chelating growth factors from mycobacteria. Bacteriological Reviews. ,vol. 34, pp. 99- 125 ,(1970) , 10.1128/BR.34.2.99-125.1970
H W Taber, J P Mueller, P F Miller, A S Arrow, Bacterial uptake of aminoglycoside antibiotics. Microbiological Research. ,vol. 51, pp. 439- 457 ,(1987) , 10.1128/MR.51.4.439-457.1987
Giovanna Poce, Robert H. Bates, Salvatore Alfonso, Martina Cocozza, Giulio Cesare Porretta, Lluís Ballell, Joaquin Rullas, Fátima Ortega, Alessandro De Logu, Emanuela Agus, Valentina La Rosa, Maria Rosalia Pasca, Edda De Rossi, Baojie Wae, Scott G. Franzblau, Fabrizio Manetti, Maurizio Botta, Mariangela Biava, Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0056980
David J. Payne, Michael N. Gwynn, David J. Holmes, David L. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery Nature Reviews Drug Discovery. ,vol. 6, pp. 29- 40 ,(2007) , 10.1038/NRD2201
Ritu Bansal-Mutalik, Hiroshi Nikaido, Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 4958- 4963 ,(2014) , 10.1073/PNAS.1403078111
Grace Mugumbate, John P. Overington, The relationship between target-class and the physicochemical properties of antibacterial drugs. Bioorganic & Medicinal Chemistry. ,vol. 23, pp. 5218- 5224 ,(2015) , 10.1016/J.BMC.2015.04.063
Kyu Y. Rhee, Luiz Pedro Sorio de Carvalho, Ruslana Bryk, Sabine Ehrt, Joeli Marrero, Sae Woong Park, Dirk Schnappinger, Aditya Venugopal, Carl Nathan, Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier Trends in Microbiology. ,vol. 19, pp. 307- 314 ,(2011) , 10.1016/J.TIM.2011.03.008
Christopher M. Jones, Ryan M. Wells, Ashoka V. R. Madduri, Matthew B. Renfrow, Colin Ratledge, D. Branch Moody, Michael Niederweis, Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 1945- 1950 ,(2014) , 10.1073/PNAS.1311402111
V. Makarov, G. Manina, K. Mikusova, U. Mollmann, O. Ryabova, B. Saint-Joanis, N. Dhar, M. R. Pasca, S. Buroni, A. P. Lucarelli, A. Milano, E. De Rossi, M. Belanova, A. Bobovska, P. Dianiskova, J. Kordulakova, C. Sala, E. Fullam, P. Schneider, J. D. McKinney, P. Brodin, T. Christophe, S. Waddell, P. Butcher, J. Albrethsen, I. Rosenkrands, R. Brosch, V. Nandi, S. Bharath, S. Gaonkar, R. K. Shandil, V. Balasubramanian, T. Balganesh, S. Tyagi, J. Grosset, G. Riccardi, S. T. Cole, Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis Science. ,vol. 324, pp. 801- 804 ,(2009) , 10.1126/SCIENCE.1171583